Pop

In May, newly reported survey data from KFF showed that one in eight adults (12%) have tried a GLP-1 agonist — the class of drugs that includes Ozempic. So, it's no surprise that several wellness- and supplement-focused brands have launched products intended to meet the moment, though each of the products discussed in this piece positions itself slightly differently and uses different ingredients. In addition to supplements created to "mimic" the effects of drugs like Ozempic, there is also a growing segment of products to support users of GLP-1 medications, both in the supplement space and in grocery aisles.